CRISM' Therapeutics CRTX.L · GBp

Its shares trade on LSE under the ticker CRTX.L. It has been listed since 15 March 2006. In the fiscal year to 31 December 2025, it reported revenue of £231,000 and a net loss of £1.9m. At that date it held total assets of £1.8m and shareholders' equity of £1.4m.

Amur Minerals Corp. locates, evaluates, acquires, explores and develops mineral properties and projects in the Russian Far East. The company is headquartered in Khabarovsk, Khabarovskiy Kray. The company went IPO on 2006-03-15. The firm and its subsidiaries locate, evaluate, acquire, explore and develop mineral properties and projects in the Russian Far East. The firm's principal asset is the Kun-Manie sulfide nickel, copper project located in Amur Oblast, with JORC resources in excess of 830,000 nickel equivalent tons. The firm's Kun-Manie project is involved in the exploration for minerals within the Kun-Manie license areas in Russia. The firm's project license area covers approximately 36 square kilometers. The firm's wholly owned subsidiary is ZAO Kun-Maine.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Robert SchaferIndependent Non-Executive Chairman of the Board$58,000
• Mr. Robin YoungChief Executive Officer, Executive Director, since 2004$318,000
• Mr. Thomas BowensNon-Executive Independent Director$50,000
• Mr. Paul GazzardNon-Executive Independent Director$76,000

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.